133 related articles for article (PubMed ID: 7907148)
1. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.
Liégeois JF; Rogister FA; Bruhwyler J; Damas J; Nguyen TP; Inarejos MO; Chleide EM; Mercier MG; Delarge JE
J Med Chem; 1994 Feb; 37(4):519-25. PubMed ID: 7907148
[TBL] [Abstract][Full Text] [Related]
2. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
[TBL] [Abstract][Full Text] [Related]
3. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
7. New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study.
Liégeois JF; Bruhwyler J; Damas J; Nguyen TP; Chleide EM; Mercier MG; Rogister FA; Delarge JE
J Med Chem; 1993 Jul; 36(15):2107-14. PubMed ID: 8101877
[TBL] [Abstract][Full Text] [Related]
8. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies.
Campiani G; Butini S; Gemma S; Nacci V; Fattorusso C; Catalanotti B; Giorgi G; Cagnotto A; Goegan M; Mennini T; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2002 Jan; 45(2):344-59. PubMed ID: 11784139
[TBL] [Abstract][Full Text] [Related]
10. The importance of serotonin-dopamine interactions in the action of clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):22-9. PubMed ID: 1358125
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Pyrido-annelated Diazepines, Oxazepines and Thiazepines.
Muylaert K; Jatczak M; Mangelinckx S; Stevens CV
Curr Med Chem; 2016; 23(42):4784-4823. PubMed ID: 27655072
[TBL] [Abstract][Full Text] [Related]
12. Homology Modeling Inspired Synthesis of 5-HT2A Receptor Inhibitors: A Diazepine Analogue of the Atypical Antipsychotic JL13.
Mongeau E; Yuan G; Minden Z; Waldron S; Booth R; Felsing D; Ondrechen MJ; Jones GB
Cent Nerv Syst Agents Med Chem; 2017; 17(3):239-244. PubMed ID: 28462720
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and angiotensin converting enzyme-inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. III.
Itoh K; Kori M; Inada Y; Nishikawa K; Kawamatsu Y; Sugihara H
Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3747-61. PubMed ID: 3028653
[No Abstract] [Full Text] [Related]
14. Synthesis and angiotensin converting enzyme inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. II.
Itoh K; Kori M; Inada Y; Nishikawa K; Kawamatsu Y; Sugihara H
Chem Pharm Bull (Tokyo); 1986 May; 34(5):2078-89. PubMed ID: 3017586
[No Abstract] [Full Text] [Related]
15. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents.
Davis DA; de Paulis T; Janowsky A; Smith HE
J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652
[TBL] [Abstract][Full Text] [Related]
16. Hypochlorous acid, a major oxidant produced by activated neutrophils, has low effect on two pyridobenzazepine derivatives, JL 3 and JL 13.
Liégeois JF; Zahid N; Bruhwyler J; Uetrecht J
Arch Pharm (Weinheim); 2000 Mar; 333(2-3):63-7. PubMed ID: 10783520
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E
J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and angiotensin converting enzyme inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. I.
Itoh K; Kori M; Inada Y; Nishikawa K; Kawamatsu Y; Sugihara H
Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1128-47. PubMed ID: 3015433
[No Abstract] [Full Text] [Related]
19. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
Meltzer HY; Matsubara S; Lee JC
Psychopharmacol Bull; 1989; 25(3):390-2. PubMed ID: 2576319
[TBL] [Abstract][Full Text] [Related]
20. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
